Bortezomib-pinanediol

CAS No. 205393-22-2

Bortezomib-pinanediol( —— )

Catalog No. M21104 CAS No. 205393-22-2

Bortezomib-pinanediol is a proteasome inhibitor. is a prodrug of Bortezomib.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 34 In Stock
50MG 47 In Stock
100MG 68 In Stock
200MG 100 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bortezomib-pinanediol
  • Note
    Research use only, not for human use.
  • Brief Description
    Bortezomib-pinanediol is a proteasome inhibitor. is a prodrug of Bortezomib.
  • Description
    Bortezomib-pinanediol is a proteasome inhibitor. is a prodrug of Bortezomib.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Proteasome/Ubiquitin
  • Target
    Proteasome
  • Recptor
    Proteasome
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    205393-22-2
  • Formula Weight
    518.462
  • Molecular Formula
    C29H39BN4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)c1cnccn1)B1OC2CC3CC(C3(C)C)C2(C)O1
  • Chemical Name
    N-((S)-1-(((R)-3-methyl-1-((3aS4S6S7aR)-3a55-trimethylhexahydro-46-methanobenzo[d][132]dioxaborol-2-yl)butyl)amino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhaoxin Gu Xiuxiu et al. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.[J]. Acta Biomaterialia 2018.
molnova catalog
related products
  • PR-924

    A potent, specific immunoproteasome LMP7 subunit inhibitor with IC50 of 25 nM.

  • Carfilzomib

    A potent, highly selective inhibitor chymotrypsin-like activity of proteasome with IC50 of 6 nM.

  • Alvelestat

    Alvelestat is an orally bioavailable, selective and reversible inhibitor of human neutrophil elastase (NE), with potential anti-inflammatory activity.